Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)
China · Delayed Price · Currency is CNY 8.45
-0.18 (-2.09%)
Sep 10, 2026, 2:40 PM CST
SHE:300485 Revenue
Beijing Science Sun Pharmaceutical had revenue of 90.29M CNY in the quarter ending June 30, 2026, a decrease of -13.41%. This brings the company's revenue in the last twelve months to 388.64M, down -2.46% year-over-year. In the year 2025, Beijing Science Sun Pharmaceutical had annual revenue of 404.72M, down -2.82%.
Revenue (ttm)
388.64M
Revenue Growth
-2.46%
P/S Ratio
10.70
Revenue / Employee
794.77K
Employees
489
Market Cap
4.16B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 404.72M | -11.76M | -2.82% |
| Dec 31, 2024 | 416.48M | -60.09M | -12.61% |
| Dec 31, 2023 | 476.57M | -257.98M | -35.12% |
| Jan 1, 2023 | 734.55M | -316.26M | -30.10% |
| Jan 1, 2022 | 1.05B | -43.42M | -3.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.